Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Heritage Cannabis Holdings Corp HERTF

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.


PINL:HERTF - Post by User

Post by Wrywisdomon Aug 10, 2022 3:28pm
164 Views
Post# 34886048

Incredible Value. ENTG at about 25% of One Years Revenue

Incredible Value. ENTG at about 25% of One Years Revenue.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:

                   https://stockhouse.com/news/press-releases/2022/05/30/entourage-health-reports-record-first-quarter-2022-financial-results

Notwithstanding all of the prior major achievements getting us to this point, just within the past few weeks:

           -unlike so many cannabis counterparts, ENTG has shored up high level financing guaranteed for more than 2 years with no dilution, and dramatically reduces convertible debentures:

                   https://stockhouse.com/news/press-releases/2022/07/29/entourage-health-provides-update-on-credit-facilities-maturity-dates-and-amends

           -Further expands medical offerings with new products and services:

                   tockhouse.com/news/press-releases/2022/07/26/entourage-expands-medical-offerings-with-launch-of-new-services-and-products

          -Announces and exclusive Canadian licensing deal to distribute a broad range of Irwin Naturals cannabis Products:

                   https://stockhouse.com/news/press-releases/2022/08/04/irwin-naturals-cannabis-products-to-be-available-in-canada

          
...and will be introducting groundbreaking Boston Beer/Samuel Adams products at any time now:
            https://stockhouse.com/news/press-releases/2022/05/23/the-boston-beer-company-introduces-teapot-a-new-line-of-cannabis-infused-iced

         
Simply an unrivaled value, period. 
What a truly extraordinary opportunity here particularly for new investors but again, also for those seeking to cost average as well.
<< Previous
Bullboard Posts
Next >>